PMS27 COST CONSEQUENCE ANALYSIS OF RITUXIMAB TREATMENT FOR RHEUMATOID ARTHRITIS IN ISRAEL
Abstract
Authors
A Hammerman SH Klang N Liebermann T Birenboim-Gal A Shuali M Kfir
A Hammerman SH Klang N Liebermann T Birenboim-Gal A Shuali M Kfir
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now